Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery-Reference-Cited by-同舟云学术

Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery

Published:2009-12 Issue:6 Volume:2 Page:652-659
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ Arrhythm Electrophysiol

Author:

Kowey Peter R.¹,Dorian Paul¹,Mitchell L. Brent¹,Pratt Craig M.¹,Roy Denis¹,Schwartz Peter J.¹,Sadowski Jerzy¹,Sobczyk Dorota¹,Bochenek Andrzej¹,Toft Egon¹

Affiliation:

1. From the Division of Cardiovascular Disease (P.R.K.), Lankenau Hospital and Institute of Medical Research, Wynnewood, Pa; the Division of Cardiology (P.D.), St Michael’s Hospital and University of Toronto, Toronto, Ontario, Canada; Libin Cardiovascular Institute of Alberta (L.B.M.), Calgary Health Region and University of Calgary, Calgary, Alberta, Canada; Baylor College of Medicine and The Methodist Hospital (C.M.P.), Houston, Tex; the Department of Medicine (D.R.), Montreal Heart Institute and...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Hazards of postoperative atrial arrhythmias

2. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

3. Atrial fibrillation after cardiac surgery: Risk factors and their temporal relationship in prophylactic drug strategy decision

4. Atrial Fibrillation after Cardiac Surgery

5. Epidemiology, Mechanisms, and Risks

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Intravenous Vernakalant in Rapid Cardioversion of Recent Onset Atrial Fibrillation: A Retrospective Single-Centre Study;Cureus;2024-04-19

2. Comparison of efficacy of pharmacological cardioversion with antazoline and propafenone versus electrical cardioversion in atrial fibrillation during cryoablation;Advances in Interventional Cardiology;2024

3. Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure;Journal of Cardiovascular Development and Disease;2023-12-06

4. Experimental drugs for supraventricular tachycardia: an analysis of early phase clinical trials;Expert Opinion on Investigational Drugs;2023-09-02

5. Characterization of electropharmacological profile of an anti-atrial fibrillatory drug vernakalant along with potential risk toward torsade de pointes: Translational studies using isoflurane-anesthetized dogs and isolated rat aortic preparations;Journal of Pharmacological Sciences;2023-08